MANDELL, DOUGLAS and BENNETT's Principles and Practice of Infectious Diseases (2 Volume Set)

Blaser, M. — Cohen, J. — Holland, S.

10ª Edición Agosto 2025

Inglés

Tapa dura

4176 pags

8370 gr

22 x 28 x 9 cm

ISBN 9780323934992

Editorial ELSEVIER

LIBRO IMPRESO

Oferta

-5%

479,38 €455,41 €IVA incluido

460,94 €437,89 €IVA no incluido

Recíbelo en un plazo de

7 - 10 días

LIBRO ELECTRÓNICO

Oferta

-5%

366,07 €347,77 €IVA incluido

351,99 €334,39 €IVA no incluido

Acceso On Line

Inmediato

enfermedades infecciosas microbiología clínica

PART I: Basic Principles in the Diagnosis and Management of Infectious Diseases
- Section A: Microbial Pathogens
  - 1. A Molecular Perspective of Microbial Pathogenicity
  - 2. The Human Microbiome
  - 3. Prebiotics, Probiotics, and Synbiotics
- Section B: Host Defense Mechanisms
  - 4. Innate (General or Nonspecific) Host Defense Mechanisms
  - 5. Adaptive Immunity: Antibodies and Immunodefiencies
  - 6. Cell-Mediated Defense Against Infection
  - 7. Mucosal Immunity
  - 8. Granulocytic Phagocytes
  - 9. Complement and Deficiencies
  - 10. Human Genetics and Infection
  - 11. Nutrition, Immunity, and Infection
  - 12. Evaluation of the Patient with Suspected Immunodeficiency
- Section C: Epidemiology of Infectious Disease
  - 13. Principles of Applied Epidemiology for the Practice of Infectious Diseases
  - 14. Emerging and Reemerging Infectious Disease Threats
  - 15. Bioterrorism: An Overview
- Section D: Clinical Microbiology
  - 16. The Clinician and the Microbiology Laboratory: Test Ordering, Specimen Collection, and Result Interpretation
- Section E: Antiinfective Therapy
  - 17. Principles of Anti-Infective Therapy
  - 18. Molecular Mechanisms of Antibiotic Resistance in Bacteria
  - 19. Pharmacokinetics and Pharmacodynamics of Anti-Infective Agents
  - 20. Penicillins and β-Lactamase Inhibitors
  - 21. Cephalosporins and Cephalosporin/β-Lactamase Inhibitor Combinations
  - 22. Carbapenems, Carbapenem/β-Lactamase Inhibitor Combinations, and Aztreonam
  - 23. Antibiotic Allergy
  - 24. Aminoglycosides
  - 25. Tetracyclines, Tetracycline Derivatives, and Chloramphenicol
  - 26. Rifamycins
  - 27. Metronidazole
  - 28. Macrolides and Clindamycin
  - 29. Glycopeptides (Vancomycin and Teicoplanin) and Lipoglycopeptides (Telavancin, Oritavancin, and Dalbavancin)
  - 30. Streptogramins (Quinupristin-Dalfopristin) and Lipopeptides (Daptomycin)
  - 31. Polymyxins (Polymyxin B and Colistin)
  - 32. Linezolid, Tedizolid, and Other Oxazolidinones
  - 33. Sulfonamides and Trimethoprim; Trimethoprim-Sulfamethoxazole
  - 34. Quinolones
  - 35. Antibiotics in Advanced Development and Other Agents
  - 36. Urinary Tract Agents: Nitrofurantoin, Fosfomycin and Methenamine
  - 37. Topical Antibacterials
  - 38. Antimycobacterial Agents
  - 39. Bacteriophage Therapy, Endolysin Therapy and Antimicrobial Peptide Therapy
  - 40. Antifungal Agents: Polyene Antifungals
  - 41. Antifungal Drugs: Azole
  - 42. Antifungal Drugs: Echinocandins and Other Beta-D-glucan Inhibitors
  - 43. Antifungal Drugs: Flucytosine
  - 44. Antimalarial Drugs
  - 45. Drugs for Protozoal Infections Other Than Malaria
  - 46. Drugs for Helminths
  - 47. Antiviral Agents: General Principles
  - 48. Antiviral Drugs for Influenza and Other Respiratory Virus Infections Except for SARS-CoV-2
  - 49. Antivirals Against Herpesviruses
  - 50. Antiviral Drugs Against Hepatitis Viruses
  - 51. Miscellaneous Antivirals Agents (Interferons, Tecovirimat, Imiquimod, Pocapavir)
  - 52. Immunomodulators
  - 53. Hyperbaric Oxygen
  - 54. Antimicrobial Stewardship
  - 55. Designing and Interpreting Clinical Studies in Infectious Diseases
  - 56. Outpatient Parenteral Antimicrobial Therapy

Selected for 2025 Doody’s Core Titles® in Infectious Disease

Offering more in-depth coverage of epidemiology, etiology, pathology, microbiology, immunology, and treatment of infectious agents than any other infectious disease resource, Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases, 10th Edition, remains your #1 choice for authoritative, comprehensive information in this challenging field. Meticulously updated by a new editorial team led by Drs. Martin J. Blaser, Jeffrey I. Cohen, and Steven M. Holland, this two-volume masterwork brings together the knowledge and expertise of more than 650 contributing authors who are outstanding scholars and experts in their fields. For ID specialists and general practitioners alike, PPID provides a balanced, detailed perspective for any patient you encounter with a complex or difficult-to-treat infectious disease. Encyclopedic in its depth, contents, and referencing, PPID-10 is the one infectious disease book that needs to be on every practitioner’s shelf and in every medical library.

Key Features

Organizes content both by individual pathogens and by important clinical syndromes, broadening the context to clearly present relevant, complex clinical information.
Contains multiple new chapters on both SARS-CoV-2 and anti-fungal therapy, as well as new chapters on bacteriophages and related agents, infections following traumatic injuries, communication to the public about infectious diseases, and the effects of climate change on infectious diseases.
Provides up-to-date coverage of recent advances in the field: an increasing understanding of the agents, immune responses, and the growing armamentarium of diagnostics (such as nucleic acid amplification and next-generation sequencing); new treatments (such as monoclonal antibodies, new antifungals, antivirals, and phage therapy); and emerging preventive measures (such as new vaccines being developed for RSV), and our relationship with the human microbiome.
Features more than 1,500 high-quality, full-color photographs―with many new to this edition.
Shares the extensive experience of new editors Drs. Jeffrey I. Cohen and Steven M. Holland, both from Bethesda, MD, as well as a new team of expert associate editors Drs. Yohei Doi, Wendy S. Garrett, Ann R. Falsey, Eleanor Wilson, Kieren Marr, and Edward Mitre—each a leading authority in their field.
Includes perspectives from hundreds of leading experts from a truly global community, including authors from Australia, Canada, and countries in Europe, Asia, and South America.
Includes regular updates online for the life of the edition.
An eBook version is included with purchase. The eBook allows you to access all of the text, figures and references, with the ability to search, customize your content, make notes and highlights, and have content read aloud. Additional digital ancillary content may publish up to 6 weeks following the publication date.

Author Information
Edited by Martin J. Blaser, MD, Henry Rutgers Chair of the Human Microbiome, Professor of Medicine and Pathology & Laboratory Medicine - RWJMS; Director, Center for Advanced Biotechnology and Medicine, Rutgers University, Piscataway, New Jersey, USA; Jeffrey I. Cohen, MD, Bethesda, MD and Steven M. Holland, MD, Bethesda, MD

MANDELL, DOUGLAS and BENNETT's Principles and Practice of Infectious Diseases (2 Volume Set)

Blaser, M. — Cohen, J. — Holland, S.

ISBN 9780323934992

Editorial ELSEVIER

LIBRO IMPRESO

LIBRO ELECTRÓNICO

Section B: Prion Diseases

Section C: Chlamydial Diseases

Section D: Mycoplasma Diseases

Section E: Rickettsioses, Ehrlichioses, and Anaplasmoses

Section F: Bacterial Diseases

Sub-Section I. Infections due to Gram-Positive Bacteria

Sub-Section II. Infections due to Gram-Negative Bacteria

Sub-Section III. Infections due to Spirochetal Bacteria

Sub-Section IV. Infections due to Anaerobic Bacteria

Sub-Section V. Infections due to Acid-Fast Organisms

Section G: Mycoses

Section H: Protozoal Diseases

Section I: Diseases Due to Toxic Algae

Section J: Diseases Due to Helminths

Section K: Ectoparasitic Diseases

Section L: Diseases of Unknown Etiology

PART IV: SPECIAL PROBLEMS

Section A: Nosocomial Infections

Section B: Infections in Special Hosts

Section C: Surgical- and Trauma-Related Infections

Section D: Immunization

Section E: Protection of Travelers

Section F: Emerging Issues in Infectious Diseases